Global blood type special centrifuge market is expanding as transfusion services, blood centers, and hospitals invest in standardized immunohematology workflows. Valued at USD 195.3 million in 2025, the market is estimated at USD 211.9 million in 2026 and is projected to reach USD 407.0 million by 2034, registering an 8.5% CAGR from 2026 to 2034.
Blood type special centrifuges are compact or benchtop systems designed for workflows including ABO/Rh typing, antibody screening, compatibility testing, red-cell washing, and gel-card or microcolumn agglutination procedures.
Access the complete report:
https://www.24lifesciences.com/blood-type-special-centrifuge-market-14667
Emerging Healthcare Trends Shaping Market Evolution
The blood-bank centrifuge market is moving toward programmable controls, automated program selection, flexible rotor configurations, and multi-format testing.
Gel-card and microcolumn agglutination workflows are increasing demand for dedicated card-compatible centrifuges. Multi-format systems that accommodate both tubes and cards can reduce equipment duplication while supporting multiple laboratory procedures.
Digital control is another important development. Microprocessor-based systems can standardize RCF, timing, acceleration, and deceleration, reducing operator variability.
Laboratory connectivity represents another emerging opportunity as blood-bank equipment increasingly becomes integrated with information systems, electronic quality records, barcode identification, and workflow traceability.
Key Market Drivers Supporting Long-Term Expansion
- Growing global blood collection and transfusion activity
- Increasing demand for standardized immunohematology workflows
- Expansion of gel-card testing
- Need for reproducible blood-grouping procedures
- Modernization of blood-bank infrastructure
- Adoption of programmable centrifuges
- Growth of transfusion services in emerging markets
WHO reported 120.4 million blood donations globally in its June 2026 blood-safety update, highlighting the scale of infrastructure supporting transfusion services.
Download segment insights:
https://www.24lifesciences.com/download-sample/14667/blood-type-special-centrifuge-market
Competitive Landscape: Companies Advancing Blood-Bank Centrifugation
The market includes immunohematology specialists, laboratory-equipment manufacturers, and regional suppliers.
- Grifols – maintains blood-grouping and antibody-testing equipment within its transfusion portfolio.
- Bio-Rad Laboratories – provides systems supporting ID-Cards, tubes, automated head detection, and cell washing.
- Meditech Technologies India – supplies dedicated blood-bank centrifuges across different capacity configurations.
- LABOAO – offers non-refrigerated blood-bank centrifuges and programmable benchtop systems.
- BIOBASE Group – supplies gel-card centrifuges and programmable immune-blood centrifuges.
Other profiled companies include Thomas Scientific, HERMLE Labortechnik, Esco Scientific, and DSC.
Segment Insights & Regional Overview
By Type, the market covers non-refrigerated and refrigerated/other specialized configurations. Non-refrigerated systems lead because routine blood grouping and compatibility workflows generally use short room-temperature cycles.
By Application, blood centers represent the largest specialized application, followed by hospitals and other facilities.
By Test Format, the market includes tube testing, gel-card/microcolumn agglutination, cell washing, and mixed card-and-tube workflows.
By Capacity, the market includes low-capacity, medium-capacity, and high-throughput benchtop systems. Medium-capacity systems serve a broad range of hospital blood banks and regional laboratories.
Regionally, North America leads with approximately 40% of 2025 market revenue. Europe has standardized blood services and established gel-card adoption. Asia-Pacific is the fastest-growing major region as blood collection, hospital infrastructure, and centralized transfusion services expand. Latin America and the Middle East & Africa provide additional opportunities through blood-system modernization.
Explore market forecasts:
https://www.24lifesciences.com/blood-type-special-centrifuge-market-14667
Technological Advancements & Strategic Outlook
Can Automated Blood-Bank Workflows Improve Transfusion Testing?
The next phase of market development will focus on programmable protocols, automatic rotor/head recognition, card-and-tube flexibility, traceability, and electronic quality records.
Manufacturers are increasingly developing systems that simplify multiple immunohematology procedures while maintaining validated centrifugation parameters.
Key Benefits of the 24LifeSciences Report
- Market sizing and forecast through 2034
- Analysis by type, application, test format, and capacity
- Regional market assessment
- Competitive analysis of blood-bank equipment suppliers
- Review of automation and workflow standardization
- Analysis of gel-card and tube-based testing technologies
Access the complete report:
https://www.24lifesciences.com/blood-type-special-centrifuge-market-14667
Future Perspective
The blood type special centrifuge market is expected to expand alongside blood-service modernization, increasing transfusion activity, and adoption of standardized immunohematology workflows. Programmable controls, multi-format systems, and laboratory connectivity will remain important areas of product differentiation.
About 24LifeSciences
Founded in 2017, 24LifeScience provides market intelligence and analytics for organizations operating across the global life sciences and healthcare industries, supporting strategic decisions through research covering emerging technologies, market dynamics, competitive landscapes, and growth opportunities.
Asia: +91 9425150513
Website: http://www.24lifesciences.com
